NCERT grounding
Section 10.3 of the NCERT Class 12 chapter Biotechnology and its Applications defines the term, lists the species in which transgenics have been produced, and enumerates five reasons for making them. Every sentence on this page has been mined for question stems — option strings such as "alpha-1-antitrypsin / emphysema", "Rosie / 2.4 grams per litre", and "polio vaccine safety / monkeys" are pulled verbatim into options. The corresponding NIOS lesson (Chapter 30, Section 30.8) adds methodology — microinjection into the male pronucleus and the retroviral vector route — which NEET occasionally uses for one-line traps.
"Animals that have had their DNA manipulated to possess and express an extra (foreign) gene are known as transgenic animals."
— NCERT Class 12, Section 10.3
Five uses of transgenic animals
NCERT clusters the entire scientific rationale for transgenic animals into a numbered list of five applications. The wording on the textbook page is dense, but the five "buckets" are mutually exclusive and easy to memorise once you tie each one to a named example or a named disease. Confusing one bucket for another — for instance, dropping alpha-1-antitrypsin into "vaccine safety" instead of "biological products" — is the single most common mistake on this topic.
Read the five uses below as a checklist. For NEET, you should be able to produce the list cold, attach the right example to each entry, and recognise distractors built by swapping examples across buckets.
1 · Normal physiology & development
Study how genes are regulated and how they affect normal functioning of the body and its development.
NCERT example: insulin-like growth factor (IGF). Genes from other species that alter IGF formation are introduced, and the resulting biological effects reveal the factor's role.
Bucket cue: "gene regulation / growth"2 · Study of disease
Transgenic animals act as disease models, increasing understanding of how genes contribute to disease and enabling new treatments to be tested.
Four diseases on the NEET list: cancer, cystic fibrosis, rheumatoid arthritis, Alzheimer's.
Bucket cue: "models for human diseases"3 · Biological products
Animals engineered to secrete human proteins (often in milk) that would otherwise be expensive to manufacture.
Three named products: α-1-antitrypsin (emphysema), human protein factor IX (haemophilia), human alpha-lactalbumin (Rosie, 1997).
Bucket cue: "milk / human protein"4 · Vaccine safety
Transgenic mice are being developed to test the safety of vaccine batches before human use.
NCERT example: polio vaccine. If reliable, transgenic mice could replace monkeys for this purpose.
Bucket cue: "polio · replace monkeys"5 · Chemical safety / toxicity testing
Same procedure as drug-toxicity testing. Animals carry genes that make them more sensitive to toxins than wild-type animals.
Outcome: faster results, fewer large animals — transgenic mice replace bigger species.
Bucket cue: "more sensitive · less time"Why over 95 per cent of all transgenic animals are mice
NCERT records that transgenic rats, rabbits, pigs, sheep, cows and fish have all been produced, but writes plainly that over 95 per cent of existing transgenic animals are mice. This statistic is the highest-yield single fact on the page; it appears as a stand-alone option in match-the-column items. The reasons it is true are practical rather than biological — mice are not unique in their genetics, only in their usability.
NCERT key fact
"Over 95 per cent of all existing transgenic animals are mice." Rats, rabbits, pigs, sheep, cows and fish make up the remainder. Memorise the species list — NEET sometimes swaps in birds or amphibians as distractors.
The case for mice rests on five practical advantages. They are small (cheap to house), reproduce rapidly (short generation time), produce large litters (statistical power), have a fully sequenced genome (since 2002), and — crucially — their fertilised eggs are large enough to accept microinjection of foreign DNA into the male pronucleus without lethal damage. The retroviral vector route works in mouse pre-implantation embryos for the same anatomical reasons. Together these make mice the de-facto standard for the entire field.
Named transgenic animals and products
NEET options recycle the same handful of names. Hold all of these in active recall: Rosie (cow, 1997, human alpha-lactalbumin, 2.4 grams per litre); α-1-antitrypsin (treats emphysema); factor IX (treats haemophilia); and the four NCERT-listed disease models — cancer, cystic fibrosis, rheumatoid arthritis, Alzheimer's. NIOS adds transgenic goats (tissue plasminogen activator, tPA, dissolves blood clots for heart-attack and stroke patients) and Chinese hamster ovary cells (factor VIII, haemophilia A). NCERT itself names the rat IGF transgenic mouse only obliquely; treat it as an illustration of physiology research, not a stand-alone product.
How a transgenic animal is made (NIOS supplement)
NCERT does not narrate the method; NIOS Section 30.8 does. The classic procedure is microinjection of foreign DNA into the male pronucleus of a fertilised egg. The retroviral-vector route — infection of pre-implantation embryos with a retrovirus carrying the foreign DNA — is the alternative. The full microinjection workflow is summarised below; expect occasional NEET items asking which step uses what.
Pronuclear microinjection — eight steps (NIOS 30.8)
- Step 1
Collect oocytes
Recovered from female parent surgically or post-slaughter.
- Step 2
In-vitro maturation
Oocytes matured in culture before fertilisation.
- Step 3
In-vitro fertilisation
Fertilised with male semen in the dish.
- Step 4
Centrifuge
Concentrates yolk so the male pronucleus is visible.
- Step 5
Microinjection
100–1000 copies of the gene injected into the male pronucleus.
- Step 6
In-vitro embryo development
Embryos cultured to a transferable stage.
- Step 7
Implant in foster mother
Non-surgical implantation of one embryo.
- Step 8
Screen offspring
DNA of offspring screened for the transgene.
Figure 1. The fertilised egg is immobilised on a holding pipette (left). A fine micropipette (right) delivers foreign DNA — typically 100 to 1000 copies of the transgene — into the larger male pronucleus. After microinjection, the embryo is cultured in vitro and then transferred non-surgically into a foster mother.
Ethical concerns (NEET reference level)
NCERT does not develop a separate ethical analysis for transgenic animals; the broader Section 10.4 — covered on a sibling page — applies. For NEET at this level, two points matter. First, the manipulation of living organisms cannot proceed unregulated, which is why India established the Genetic Engineering Appraisal Committee (GEAC) to approve GM research and the release of GM organisms (PYQ NEET 2018). Second, transgenic-animal production raises specific concerns about animal welfare, the unpredictability of off-target genome edits, and the equitable sharing of benefits from products derived from genetic material long used by traditional communities (the biopiracy theme). These remain general principles; deeper ethical analysis sits with the dedicated GEAC subtopic.
Worked examples
Q. A transgenic cow named Rosie produced human protein-enriched milk. The protein concerned and the year of the achievement are, respectively:
A. Human alpha-lactalbumin, in 1997. NCERT records that the milk contained 2.4 grams per litre of this human protein and was nutritionally a more balanced product for human babies than natural cow milk. Distractors that pair Rosie with α-1-antitrypsin (a sheep example) or with factor IX (haemophilia) are common; the correct linkage is Rosie → alpha-lactalbumin → infant nutrition.
Q. Statement I: Over 95 per cent of existing transgenic animals are mice. Statement II: Transgenic mice are used to test the safety of polio vaccines and could replace monkeys for this purpose. Which is correct?
A. Both statements are correct and both are NCERT statements. Statement I is the headline fact about why mice dominate the field; Statement II is one specific application — vaccine safety testing — given in NCERT Section 10.3 (iv). Mice are made transgenic for the human poliovirus receptor so they respond to the virus like primates do; this could replace monkey-based safety testing for polio vaccine batches.
Q. Match the transgenic product with its clinical use: (A) α-1-antitrypsin (B) Factor IX (C) Alpha-lactalbumin (D) Tissue plasminogen activator. Choices: (I) Haemophilia (II) Emphysema (III) Dissolves blood clots (IV) Enriched milk.
A. A–II, B–I, C–IV, D–III. α-1-antitrypsin treats emphysema; factor IX treats haemophilia; alpha-lactalbumin enriched the milk of Rosie; tissue plasminogen activator from transgenic goats dissolves clots in coronary thrombosis. NEET 2024 used a similar A–B–C–D match with α-1-antitrypsin and Cry-genes — keep the product-to-use map intact in active recall.
Q. Which of the following is not among the four human diseases for which transgenic models are listed in NCERT Section 10.3? Options: (1) cancer (2) cystic fibrosis (3) sickle-cell anaemia (4) Alzheimer's.
A. (3) sickle-cell anaemia. The four NCERT-listed transgenic disease models are cancer, cystic fibrosis, rheumatoid arthritis and Alzheimer's. Sickle-cell anaemia features elsewhere in the chapter (gene therapy / hereditary disease discussions) but is not on the transgenic-animal list. NEET frequently builds "all of the following except" stems on exactly this four-item set.
Common confusion & NEET traps
Biological products (Use #3)
Produce a useful protein in the animal's body / milk
- α-1-antitrypsin → emphysema
- Factor IX → haemophilia
- Alpha-lactalbumin → Rosie (1997, 2.4 g/L)
- Attempts also for PKU, cystic fibrosis
Vaccine safety (Use #4)
Use the animal as a sensitive testing system
- Transgenic mice express viral receptors
- Polio vaccine safety testing
- If reliable, replaces monkeys
- No human protein is harvested